Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SBC 101

Next Previous
Drug Profile

SBC 101

Alternative Names: AI-1944; AIC-101; SBC-101; SBC-101K; SBC-101L; YDC-105

Latest Information Update: 21 Aug 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ailon
  • Developer SapiensBio; YD Global Life Science
  • Class Antifibrotics; Small molecules
  • Mechanism of Action ARPC2 protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Hepatic fibrosis; Renal fibrosis
  • No development reported Idiopathic pulmonary fibrosis

Most Recent Events

  • 31 Jul 2026 SBC 101 is still in preclinical trials for Idiopathic pulmonary fibrosis in South Korea (PO) (YD Global Life Science pipeline, August 2026)
  • 30 Jul 2026 YD Global Life Science files an IND application with the US FDA in USA for Idiopathic pulmonary fibrosis
  • 28 May 2026 No recent reports of development identified for preclinical development in Idiopathic-pulmonary-fibrosis in South Korea (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top